Nyxoah SA Stock, NASDAQ:NYXH
Rue Edouard Belin 12, Mont-Saint-Guibert, Walloon Region 1435
Number of Employees: 105.8
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.